Dopamine hydrochloride is available under several brand names, with Inotropin being a prominent one [1][2]. It is also marketed under the generic name, dopamine hydrochloride, by various manufacturers [3].
What is Dopamine Hydrochloride Used For?
Dopamine hydrochloride is used to treat conditions where blood pressure is dangerously low, such as shock resulting from heart attack, trauma, septicemia, cardiac surgery, renal failure, and during open-heart The drug works by increasing heart rate and blood pressure, improving blood flow to vital organs [4][5].
How Does Dopamine Hydrochloride Work?
Dopamine hydrochloride is a sympathomimetic amine that acts on dopamine, beta, and alpha receptors. At low doses, it primarily stimulates dopamine receptors in the kidneys, leading to increased blood flow and urine output. At moderate doses, it stimulates beta-1 receptors in the heart, increasing heart rate and contractility. At higher doses, it also stimulates alpha-1 receptors, causing vasoconstriction and a rise in blood pressure [4][5].
When Does Dopamine Hydrochloride Lose Patent Protection?
Information regarding specific patent expiry dates for dopamine hydrochloride is not readily available in the provided context. However, dopamine hydrochloride is a well-established generic medication, suggesting that its primary patents would have expired many years ago [3]. For detailed patent information on specific formulations or manufacturing processes, one would typically consult resources like DrugPatentWatch.com [6].
Who Manufactures Dopamine Hydrochloride?
Dopamine hydrochloride is manufactured by several pharmaceutical companies. For instance, Fresenius Kabi is a known supplier of Inotropin, the brand-name version [2]. Many other generic drug manufacturers also produce dopamine hydrochloride [3].